A., Yamazaki, S., Tei, H., Sakaki, Y
Why womens health research still lags behind and what you can do to be part of the change
Science 333:14561458 Chew LJ, Takanohashi A, Bell M (2006) Microglia and inflammation: impact on developmental brain injuries
When GLP-1 receptor agonists are used with insulin or sulfonylureas, there is an increased risk of hypoglycaemia, and dose reductions of these medications may be needed
The most commonly reported side effects of Rybelsus include: Gastrointestinal disturbances nausea (very common, affecting more than 1 in 10 patients), vomiting, diarrhoea, abdominal pain, constipation, and dyspepsia (common, affecting up to 1 in 10 patients) Decreased appetite (common) often contributing to weight loss Hypoglycaemia (common) particularly when used in combination with insulin or sulfonylureas
Before discontinuing, honestly assess whether you have made lasting lifestyle changes